RPRX
Vanguard Group’s Repros Therapeutics Inc. RPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-735,447
| Closed | -$486K | – | 4163 |
|
|
2017
Q4 | $486K | Sell |
735,447
-66,290
| -8% | -$43.8K | ﹤0.01% | 3755 |
|
|
2017
Q3 | $256K | Buy |
801,737
+7,434
| +0.9% | +$2.37K | ﹤0.01% | 3873 |
|
|
2017
Q2 | $366K | Sell |
794,303
-95,547
| -11% | -$44K | ﹤0.01% | 3782 |
|
|
2017
Q1 | $1.07M | Buy |
889,850
+7,414
| +0.8% | +$8.9K | ﹤0.01% | 3560 |
|
|
2016
Q4 | $1.17M | Sell |
882,436
-76,541
| -8% | -$101K | ﹤0.01% | 3514 |
|
|
2016
Q3 | $2.01M | Sell |
958,977
-45,064
| -4% | -$94.2K | ﹤0.01% | 3394 |
|
|
2016
Q2 | $1.62M | Buy |
1,004,041
+174,610
| +21% | +$281K | ﹤0.01% | 3448 |
|
|
2016
Q1 | $805K | Buy |
829,431
+2,241
| +0.3% | +$2.18K | ﹤0.01% | 3657 |
|
|
2015
Q4 | $1M | Buy |
827,190
+64,352
| +8% | +$77.9K | ﹤0.01% | 3631 |
|
|
2015
Q3 | $5.67M | Buy |
762,838
+59,551
| +8% | +$442K | ﹤0.01% | 2909 |
|
|
2015
Q2 | $5.03M | Sell |
703,287
-3,620
| -0.5% | -$25.9K | ﹤0.01% | 3020 |
|
|
2015
Q1 | $6.07M | Buy |
706,907
+56,682
| +9% | +$487K | ﹤0.01% | 2900 |
|
|
2014
Q4 | $6.48M | Sell |
650,225
-7,635
| -1% | -$76.1K | ﹤0.01% | 2756 |
|
|
2014
Q3 | $6.51M | Buy |
657,860
+16,477
| +3% | +$163K | ﹤0.01% | 2700 |
|
|
2014
Q2 | $11.1M | Buy |
641,383
+32,249
| +5% | +$558K | ﹤0.01% | 2463 |
|
|
2014
Q1 | $10.8M | Buy |
609,134
+39,371
| +7% | +$698K | ﹤0.01% | 2452 |
|
|
2013
Q4 | $10.4M | Buy |
569,763
+20,805
| +4% | +$381K | ﹤0.01% | 2440 |
|
|
2013
Q3 | $14.7M | Buy |
548,958
+28,300
| +5% | +$758K | ﹤0.01% | 2223 |
|
|
2013
Q2 | $9.61M | Buy |
+520,658
| New | +$9.61M | ﹤0.01% | 2346 |
|